Ace Vision Group Appoints Elizabeth Yeu, MD, as Chief Strategic Advisor

Ace Vision Group announced that Elizabeth Yeu, MD, partner at Virginia Eye Consultants, has been appointed to the role of chief strategic advisor. In her new position, Dr. Yeu will manage AVG's clinical advancement strategy.

As a surgeon, researcher, and educator, Dr. Yeu has contributed greatly to the field of ophthalmology throughout her more than 20-year career. Dr. Yeu is an avid proponent of novel technologies and disruptive therapeutics that improve the current standard of care for patients.

"I am excited to begin working with AVG in this capacity. I have closely followed the ongoing development of the Laser Scleral Microporation (LSM) technology which began with restoring the loss of dynamic range of focus (DRoF) related to the manifestation of presbyopia," Dr. Yeu said. "I have been impressed by the detailed science behind the VisioLite technology and the clinical results of the multiple LSM studies. The sustainability of the results of each, as well as the consistent reproducible clinical results seen from patient to patient are noteworthy. I am looking forward to serving in this role with AnnMarie Hipsley, DPT, PhD and the AVG executive management team."

AVG is a privately held U.S. ophthalmic medical device company developing Laser Microporation Therapeutic technologies to treat diseases of the aging eye. The LSM technology is a minimally invasive rejuvenation procedure for the treatment of presbyopia, glaucoma, and other eye diseases. Currently, AVG is preparing for the commercialization of its VisioLite ophthalmic laser system, an innovative, first-in-class touchless laser technology offering.